Physician

Todd Vincent Panarese, M.D.

According to 2025 Medicare claims, Todd Panarese, M.D. (NPI: 1427125053) practices radiation oncology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is CANCER CARE CENTERS OF BREVARD INC (NPI: 1467551762; TIN: 593169766) and primary practice location at 32952-3114. Panarese is affiliated with the Primary Care Alliance, LLC (ACO ID: D0010), participating under the REACH model.

Panarese's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 552 traditional Medicare patients, billed 10,075 HCPCS/CPT codes, and received $1,317,975 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 200 prescription claims across 94 beneficiaries totaling $2,825 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 57 records totaling $1,791. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $804,310 to $1,317,975. Similarly, Part D prescription costs have risen steadily, from $2,210 to $2,825. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	326	6,314	$804,310
2016	264	5,019	$641,415
2017	251	5,324	$718,342
2018	432	6,510	$825,273
2019	460	7,366	$1,029,847
2020	437	7,306	$1,034,239
2021	431	6,869	$964,680
2022	478	7,466	$1,084,104
2023	571	9,768	$1,246,698
2024	552	10,075	$1,317,975

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	42	97	$2,210
2016	48	80	$1,467
2017	49	128	$2,098
2018	50	92	$1,431
2019	36	65	$2,142
2020	47	110	$2,710
2021	51	109	$3,282
2022	60	125	$2,804
2023	88	173	$4,127
2024	94	200	$2,825

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	176	1,943	$282
G6012	Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev	81	714	$181
77336	Continuing radiation therapy consultation per week	78	482	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	204	328	$65
G6002	Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy	200	1,944	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	117	7,000	$1,480
Oxycodone Hcl	Oxycodone Hcl	11	66	$75
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	82	$71

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	57	$1,791	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Todd Vincent Panarese, M.D.?

Tedicare shows public-source Medicare data for Todd Vincent Panarese, M.D. (NPI 1427125053), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Todd Vincent Panarese, M.D. have ACO affiliation data?

Todd Vincent Panarese, M.D. is shown with ACO affiliation data for Primary Care Alliance, LLC (REACH, ACO ID D0010).

What billing organization is linked to Todd Vincent Panarese, M.D.?

Todd Vincent Panarese, M.D. is linked to CANCER CARE CENTERS OF BREVARD INC (billing NPI 1467551762) in the available physician profile data.

Does Todd Vincent Panarese, M.D. have Open Payments data?

Todd Vincent Panarese, M.D. has 57 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.